A Prospective Observational Study to Assess the Long-Term Safety of Baricitinib Compared with Other Therapies Used in the Treatment of Adults in the United States with Moderate-to-Severe Rheumatoid Arthritis in the Course of Routine Clinical Care (I4V-MC-B003)